Qube Research & Technologies LTD Vertex Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 453,373 shares of VRTX stock, worth $210 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

453,373

Previous 558,536 18.83%

Holding current value

$210 Million

Previous $233 Million 8.98%

% of portfolio

0.34%

Previous 0.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $41.3 Million - $51.1 Million	-105,163 Reduced 18.83%	453,373 $213 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $38.1 Million - $41.7 Million	93,511 Added 20.11%	558,536 $233 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $15.7 Million - $18.9 Million	45,916 Added 10.96%	465,025 $189 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $115 Million - $123 Million	339,462 Added 426.21%	419,109 $146 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $25 Million - $28 Million	79,647 New	79,647 $28 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $94.5 Million - $106 Million	330,619 Added 341.16%	427,529 $123 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $26.5 Million - $29.6 Million	96,910 New	96,910 $28.1 Million
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $7.71 Million - $9.74 Million	-43,583 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $7.91 Million - $8.85 Million	43,583 New	43,583 $7.91 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $5.41 Million - $6.38 Million	-28,845 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $5.97 Million - $6.96 Million	28,845 New	28,845 $6.2 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $4.2 Million - $5.6 Million	-20,293 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $1.46 Million - $1.73 Million	5,720 Added 39.25%	20,293 $5.52 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $2.4 Million - $3.15 Million	10,665 Added 272.9%	14,573 $4.23 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1.98 Million - $2.45 Million	-9,901 Reduced 71.7%	3,908 $930,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $2.3 Million - $3.09 Million	13,809 New	13,809 $3.02 Million
Q2 2019 Aug 02, 2019	SELL	$164.61 - $190.37 $1.56 Million - $1.81 Million	-9,494 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.55 Million - $1.85 Million	9,494 New	9,494 $1.75 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $1.08 Million - $1.36 Million	-7,098 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $1.04 Million - $1.2 Million	6,209 Added 698.43%	7,098 $1.37 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $68,779 - $80,221	-472 Reduced 34.68%	889 $151,000
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $206,327 - $241,073	1,361 New	1,361 $221,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Vertex Pharmaceuticals Inc Transaction History